MedPath

Evaluation of management of anaemia during the surgery period

Not Applicable
Conditions
Health Condition 1: C15-C26- Malignant neoplasms of digestive organs
Registration Number
CTRI/2019/07/020348
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult patients (18 years or more) posted for elective gastrointestinal surgery

Exclusion Criteria

1.Patients <18 years

2.Emergency GI surgical procedures

3.Pregnant women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of anaemia management on the incidence of anaemia in patients undergoing elective GI surgeryTimepoint: Before surgery, during surgery, after surgery, at discharge from hospital and at 2 months of surgery
Secondary Outcome Measures
NameTimeMethod
1.To study the rate of allogenic blood transfusion in perioperative period in patients undergoing elective GI surgery. <br/ ><br>2.To study effect of anaemia management on preoperative Hb and pre-discharge Hb after anaemia management. <br/ ><br>3.Postoperative morbidity, mortality and length of stay. <br/ ><br>Timepoint: Before surgery, During surgery, after surgery, at discharge from hospital and at 2 months of surgery
© Copyright 2025. All Rights Reserved by MedPath